Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the COVER Cohort (Verneuil Cohort)
NCT ID: NCT04352036
Last Updated: 2025-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
465 participants
OBSERVATIONAL
2022-01-04
2030-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Polymorphisms of RAAS and MMPs in Acute Heart Failure
NCT02170961
MAP( Mean Arterial Pressure) and Mortality Relation in Patients With Heart Failure
NCT06515366
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
NCT00762008
Dynamics of Immune Map and Outcomes After On-pump Cardiac Surgery: Protocol for a Prospective Cohort Study
NCT05400356
Hemodynamics During the Soccer Championship 2012
NCT01617863
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patient
no interventional study
no interventional study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no interventional study
no interventional study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient agreeing to be part of the study
Exclusion Criteria
* Protected persons
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Angers
Angers, , France
Chru Brest
Brest, , France
CHD Vendée
La Roche-sur-Yon, , France
CH La Rochelle
La Rochelle, , France
CH
Le Mans, , France
CH bretagne sud
Lorient, , France
CHU de Nantes - Dermatologie
Nantes, , France
Chr D'Orléans
Orléans, , France
CHU Milétrie
Poitiers, , France
Ch de Cornouaille
Quimper, , France
CHU Pontchaillou
Rennes, , France
Ch Saint-Brieuc
Saint-Brieuc, , France
CHRU Tours
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Philippe Celerier, MD
Role: primary
caroline JACOBZONE-LEVEQUE
Role: primary
Brigitte Dreno, PU PH
Role: primary
eric esteve
Role: primary
patrice plantin
Role: primary
gilles safa
Role: primary
Annabel Maruani, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC19_0418
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.